Kanwar Singh, MD
Clinical Cardiac Electrophysiology · Houma, LANPI 1679807093
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,251 of the $13,552 with a category attached, or 60.9%. Medtronic accounts for 80.7% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $6,145 and has fallen 54.1% since, to $2,818 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in LA, where the typical reported total is $18,132.
Across 207 payments — averaging $65.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Abbott$1K
- Atricure, Inc.$194
- Kestra Medical Technology Services, Inc.$185
- Amgen$137
- AstraZeneca$135
- plus $716 from 11 others
Across 1 payment — averaging $15,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$15K
What the payments were for
- Consulting fees$8,25161%
- Travel & lodging$7816%
- Food & beverage$4,49033%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 102 | $10,941 |
| Abbott | 40 | $1,244 |
| Atricure, Inc. | 3 | $194 |
| Kestra Medical Technology Services, Inc. | 10 | $185 |
| Amgen(2 entities) | 4 | $137 |
| AstraZeneca | 2 | $135 |
| Abiomed | 15 | $135 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $91 |
| Pfizer | 5 | $90 |
| Cardiva Medical, Inc. | 3 | $88 |
| Johnson & Johnson | 5 | $87 |
| Boehringer Ingelheim | 5 | $76 |
| Novartis | 3 | $57 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| Boston Scientific | 1 | $21 |
| Lexicon Pharmaceuticals, Inc. | 1 | $21 |
| Terumo Medical Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,552 in reported general payments places this provider in the 40th percentile of 43 clinical cardiac electrophysiology providers in Louisiana.
See all clinical cardiac electrophysiology providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 743 | $681,698 |
| EntrestoSacubitril/Valsartan | 130 | $139,655 |
| XareltoRivaroxaban | 114 | $108,528 |
| JardianceEmpagliflozin | 54 | $49,978 |
| Metoprolol Succinate | 917 | $15,036 |
| Repatha SureclickEvolocumab | 17 | $12,455 |
| Amiodarone Hcl | 472 | $7,489 |
| Flecainide Acetate | 161 | $4,347 |
| Valsartan | 197 | $4,051 |
| Carvedilol | 396 | $3,126 |
| Dofetilide | 39 | $2,656 |
| SotalolSotalol Hcl | 88 | $2,289 |
| Ranolazine ErRanolazine | 18 | $1,888 |
| Rosuvastatin Calcium | 156 | $1,860 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 57 | $1,704 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $90 | $681,698743 claims |
| NovartisEntresto | $57 | $139,655130 claims |
| Johnson & JohnsonXarelto | $87 | $108,528114 claims |
| Boehringer IngelheimJardiance | $76 | $49,97854 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 43 clinical cardiac electrophysiology providers in Louisiana.
Other clinical cardiac electrophysiology in Houma
- Vishal VyasHouma$1K
- Nassir MarroucheNew Orleans$498K
- Sammy KhatibNew Orleans$115K
- Paul LelorierNew Orleans$101K
- Adil YousufNew Orleans$101K
- Mark PolletBaton Rouge$90K
- Joshua AymondBaton Rouge$64K
- Michael BernardNew Orleans$59K
- Dedric ClarkeNew Orleans$51K
- Eoin DonnellanLafayette$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.